Diane Delpy-Sampson

Diane Delpy-Sampson has a diverse background in the pharmaceutical and biomedical research industry. Diane is currently working as an Associate Director of program management at Imcheck Therapeutics, starting in 2022.

Prior to their current role, Diane worked at ENYO Pharma from 2016 to 2022. During their time there, they held two positions. First, they were a Program Manager, where they utilized their knowledge of pharmaceutical development to oversee an early phase project. Diane was responsible for coordinating various aspects of the project, including IND enabling studies, CMC, and clinical processes. Diane then transitioned to the role of Clinical Trial Coordinator, which involved managing the coordination and logistics of clinical trials.

From 2011 to 2016, Diane worked at Bristol-Myers Squibb. Diane held multiple positions during their time there, including Research Scientist I, associate research scientist II, and associate research scientist I. In these roles, they conducted pre-clinical research in oncology and immuno-oncology, performing in-vivo and in-vitro assays to support clinical development. Diane also had the opportunity to lead pharmacological studies for BMS's oncology and immuno-oncology programs, supervise studies, and manage scientific alliances with CRO partners.

Before joining Bristol-Myers Squibb, Diane gained research experience at Drexel University College of Medicine. Diane worked as a Research assistant II laboratory manager from 2007 to 2011, where they collaborated with various research teams and managed laboratory operations. Prior to that, they worked as an Intern at Drexel University College of Medicine in 2007, where they conducted research on the involvement of serotonin in breast cancer and created a reference database linking serotonin to breast cancer phenotypes.

Diane also gained industry experience through internships at RheoGene. Diane worked as an Intern in 2005 and 2004, where they optimized laboratory procedures and conducted research on inducible gene expression technologies.

Overall, Diane Delpy-Sampson has a deep understanding of pharmaceutical development, clinical trial coordination, and pre-clinical research in oncology and immuno-oncology. Diane has demonstrated their ability to manage projects, conduct scientific studies, and collaborate with various stakeholders.

Diane Delpy-Sampson pursued their educational journey with a strong focus on scientific disciplines. Diane completed their Master's degree in Industrial Biology from Ecole de biologie industrielle, spanning from 2002 to 2007. Following this, they furthered their education at Drexel University College of Medicine, where they obtained a Master's degree in Clinical Research from 2010 to 2012.

In addition to their formal education, Diane has also obtained certifications to enhance their professional skills. In May 2022, they completed the "Finance for Non-Financial Managers" certification from LinkedIn. Furthermore, in December 2018, they completed the "Project Management for Pharma Professionals" certification from Management Forum Ltd. These certifications highlight their commitment to augmenting their expertise and staying up-to-date in their field.